uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Genetics and Pathology.
Show others and affiliations
2007 (English)In: European Urology, ISSN 0302-2838, E-ISSN 1873-7560, Vol. 51, no 2, 416-423 p.Article in journal (Refereed) Published
Abstract [en]


The individual recurrence-free period after primary surgery of patients with Ta urothelial cell carcinoma (UCC) cannot be predicted accurately. This study aims at discriminating between patients with primary Ta UCC and long or short recurrence-free periods.


We investigated mRNA expression of 23 genes in 44 primary Ta tumours (23 and 21 tumours were from patients with long [≥4 yr] or short [≤2 yr] recurrence-free periods, respectively), using real-time quantitative polymerase chain reaction. The genes were selected from previously published studies and showed a relationship with tumour recurrence in patients with UCC.


Differential mRNA expression between the two patient groups indicated statistical significance only for the gene survivin (p = 0.0011). Its recurrence predictive value could not be increased by a combination with any of the other genes. Comparison of the receiver operating characteristic curves for survivin expression between patients with long or short recurrence-free intervals revealed an area under the curve of 0.79 (95%CI, 0.65–0.92). Using the median expression (0.84) as cut-off level, survivin identified 71.4% (95%CI, 47.8–88.7) and 69.6% (95%CI, 47.1–86.8) of the patients with long or short recurrence-free periods, respectively.


Our study identifies survivin as the most promising candidate to distinguish between patients with primary Ta UCC and long or short recurrence-free intervals. Therefore, survivin mRNA expression analysis might help the urologist to individualise patient treatment and prevent unnecessary cystoscopies in a subgroup of these patients.

Place, publisher, year, edition, pages
2007. Vol. 51, no 2, 416-423 p.
Keyword [en]
Adult, Aged, Aged; 80 and over, Carcinoma; Transitional Cell/*genetics/*surgery, Female, Gene Expression Profiling, Humans, Male, Middle Aged, Neoplasm Recurrence; Local/*genetics, Predictive Value of Tests, RNA; Neoplasm/biosynthesis, Urinary Bladder Neoplasms/*genetics/*surgery
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-15361DOI: 10.1016/j.eururo.2006.07.023ISI: 000243649000020PubMedID: 16920253OAI: oai:DiVA.org:uu-15361DiVA: diva2:43132
Available from: 2008-06-04 Created: 2008-06-04 Last updated: 2011-02-16Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16920253&dopt=Citation

Search in DiVA

By author/editor
Wester, Kenneth
By organisation
Department of Genetics and PathologyDepartment of Surgical Sciences
In the same journal
European Urology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 145 hits
ReferencesLink to record
Permanent link

Direct link